ABC Columbia
Moderna announces it plans to begin vaccine trials for children
The drug maker says they hope to have a vccine that would work for children as young as 6 months
Mar 16, 2021 9:54 PM EDT
Image: Dado Ruvic/Reuters/Illustration, Fule
The move makes Moderna the first U.S. vaccine maker to test its vaccine on infants.
Moderna’s trial will enroll nearly 7,000 children from ages 6 months to 12 years in the U.S. and Canada, according to the company.
“There will be two parts to the study,” Dr. Jacqueline Miller, a pediatrician and Moderna’s therapeutic area head for infectious diseases, told “Good Morning America.” “The first part is where we will find the appropriate dose of the vaccine.”
Moderna launches COVID-19 vaccine trial for young children
Moderna said it is expected to enroll 6,750 children from the U.S. and Canada between 6 months and less than 12 years old for this stage of the study. Author: Josh Sanders (KPNX) Updated: 5:41 PM MST March 16, 2021
PHOENIX Drug maker Moderna is the first of the three COVID-19 vaccines authorized for use in the U.S. to launch a trial testing the vaccine s efficacy and safety on children between the ages of six months and less than 12 years old.
The company said in a press release that the first participants in its Phase 2/3 study, called the KidCOVE study, have been given their first dose.
The U.S. has administered more than 110 million doses of COVID-19 vaccines, but the vast majority of those jabs are going to adults. Moderna announced Tuesday that it has begun enrolling children from 6 months to less than 12 years old into a trial of its COVID-19 vaccine.
Having the young vaccinated would bring the country another step closer to actually achieving herd immunity and protecting everybody, says Dr. Steve Plimpton, an OB-GYN in Arizona who is the principal investigator for the Moderna children s trial in Phoenix.
Pfizer s vaccine currently is authorized for people as young as 16
, and the company is testing its vaccine on 12- to 15-years-olds. The vaccines from Moderna and Johnson & Johnson currently are for people 18 and up.
John Moore/Getty Images
toggle caption John Moore/Getty Images
Nurse manager Lucy Golding draws up doses of the Moderna COVID-19 vaccine March 14 in Stamford, Conn. Moderna has begun enrolling infants and young children into a vaccine trial. John Moore/Getty Images
The U.S. has administered more than 110 million doses of COVID-19 vaccines, but the vast majority of those jabs are going to adults. Moderna announced Tuesday that it has begun enrolling children from 6 months to less than 12 years old into a trial of its COVID-19 vaccine.
Having the young vaccinated would bring the country another step closer to actually achieving herd immunity and protecting everybody, says Dr. Steve Plimpton, an OB-GYN in Arizona who is the principal investigator for the Moderna children s trial in Phoenix.
The U.S. new cases 7-day rolling average are 4.8 % LOWER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 15.2 %
LOWER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are 54,434
U.S. Coronavirus deaths are at 1,245
U.S. Coronavirus immunizations have been administered to 33.1 % of the population
The 7-day rolling average rate of growth of the pandemic shows new cases worsened and deaths improved
What we know about India s Covid-19 vaccine
AstraZeneca Vax Flops Against South African Variant in Early Trial
Some long-haul covid-19 patients say their symptoms are subsiding after getting vaccines